AVITA Medical Inc.

10.26
0.19 (1.89%)
At close: Apr 28, 2025, 3:59 PM

AVITA Medical Revenue Breakdown

Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Sep 30, 2021 Mar 31, 2021
Recell System Revenue 399K 408K 416K 432K 435K 435K 435K 4.1M
Recell System Revenue Growth -2.21% -1.92% -3.70% -0.69% 0.00% 0.00% -89.39% n/a

Revenue by Geography

Period Ending Dec 31, 2022 Jun 30, 2021 Jun 30, 2020
United States Revenue 33.26M 28.95M 13.8M
United States Revenue Growth +14.86% +109.82% n/a

Operating Expense Breakdown

Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Selling, General, and Administrative Revenue 25.78M 24.27M 22.19M 17.13M 16.28M 15.65M 16.52M 14.53M 8.87M 9.42M 11.94M 9.08M 16.16M 20.24M 27.91M 15.79M 9.93M
Selling, General, and Administrative Revenue Growth +6.23% +9.37% +29.53% +5.21% +4.07% -5.28% +13.67% +63.89% -5.88% -21.11% +31.52% -43.80% -20.18% -27.47% +76.74% +58.94% n/a
Research and Development Revenue 6.84M 7.62M 6.86M 4.96M 5.94M 4.43M 4.84M 5.78M 3.39M 3.97M 5.41M 4.36M 4.71M 3.68M 4.06M 3.3M 2.42M
Research and Development Revenue Growth -10.31% +11.10% +38.21% -16.44% +34.06% -8.41% -16.27% +70.53% -14.75% -26.54% +24.09% -7.50% +28.15% -9.36% +23.13% +36.02% n/a
Sales and Marketing Revenue 16.38M 15.02M 9.78M 9.32M 8.46M 7.72M 6.45M 6.82M 3.52M 4.15M 4.8M 4.67M 4.56M 6.17M 7.11M 5.66M 4.39M
Sales and Marketing Revenue Growth +9.09% +53.52% +5.01% +10.11% +9.55% +19.70% -5.38% +93.81% -15.15% -13.70% +2.89% +2.38% -26.12% -13.23% +25.67% +28.99% n/a